Vor Biopharma Inc.
VOR
|
|
|
|
Trading Volume | 47,803 |
|
2.85 - 0.81 |
Market Cap Full | $ 58.3M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 20% | 3.1% | -19.1% | -49.2% |
Q2 | - | -48.2% | -42.6% | -17.7% |
Q3 | - | -6.3% | -31.4% | -19.9% |
Q4 | - | 31.1% | 15.1% | 67.1% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
20 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
2.2 | - | 0.9 | -26.3 | -21.6 | -14.2 | -20 | -6.3 | - | - | - | 33.7 |
2023 | |||||||||||
-20.8 | 5.9 | -3.6 | -17.3 | 5.6 | -34.3 | -2.3 | -17.2 | -15.2 | -13.7 | 1.1 | 21.6 |
2022 | |||||||||||
-30.6 | 9.5 | -33.1 | -5.1 | -26.5 | 18.1 | -7.2 | 11.3 | -22.4 | 20.9 | -4.4 | 44.6 |
2021 | |||||||||||
- | - | -4.1 | -33 | -27 | -11.6 | -32.9 | 17.3 | 7.6 | -0.5 | -26.6 | 3 |
2020 | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | - |
EPS
2023 | 2022 | 2021 | |
---|---|---|---|
Q1 | -0.4 | -0.6 | -0.7 |
Q2 | -0.5 | -0.6 | -0.5 |
Q3 | -0.5 | -0.6 | -0.5 |
Q4 | 0 | -0.5 | -0.5 |
A | -1.37 | -2.3 | -2.1 |